FDA Approved: CLOBAZAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for CLOBAZAM (clobazam) from Aurobindo Pharma Limited, updating the existing product through a supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Lennox-gastaut Syndrome

Drugs mentioned

• CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)